## Abstract ## Objective Previous studies showed that etanercept treatment in patients with polyarticular‐course juvenile rheumatoid arthritis (JRA) provided rapid clinical improvement that was sustained for up to 2 years. The goal of our study was to provide data on safety and efficacy after 4 ye
Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis
✍ Scribed by Nicolino Ruperto; Daniel J. Lovell; Pierre Quartier; Eliana Paz; Nadina Rubio-Pérez; Clovis A. Silva; Carlos Abud-Mendoza; Ruben Burgos-Vargas; Valeria Gerloni; Jose A. Melo-Gomes; Claudia Saad-Magalhães; J. Chavez-Corrales; Christian Huemer; Alan Kivitz; Francisco J. Blanco; Ivan Foeldvari; Michael Hofer; Gerd Horneff; Hans-Iko Huppertz; Chantal Job-Deslandre; Anna Loy; Kirsten Minden; Marilynn Punaro; Alejandro Flores Nunez; Leonard H. Sigal; Alan J. Block; Marleen Nys; Alberto Martini; Edward H. Giannini
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 128 KB
- Volume
- 62
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective To determine whether vaccinations aggravate the course of autoimmune diseases such as juvenile idiopathic arthritis (JIA) and whether the immune response to vaccinations may be hampered by immunosuppressive therapy for the underlying disease. ## Methods In this multicent
## Abstract ## Objective In an international, multicenter, double‐blind, randomized clinical trial we evaluated the short‐term (3 months) and long‐term (12 months) efficacy and safety of 2 different doses of meloxicam oral suspension compared with the efficacy and safety of naproxen oral suspensio